@misc{oai:repo.qst.go.jp:00065334,
 author = {山田, 滋 and 篠藤, 誠 and 遠藤, 悟史 and 山田 滋 and 篠藤 誠 and 遠藤 悟史},
 month = {Apr},
 note = {Venous thromboembolism(VIE), which includes deep vein thrombosis(DVT) and pulmonaly embolism(PE), is a major complication of cancer and one of the leading causes of death among cancer patients.
Approximately 20% of patients diagnosed with pancreatic adenocarcinoma develop venous thromboembolism, contributing to the poor prognosis of this disease. A small phase II trial suggested longer survival with the addition of low molecular weight heparin (LMWH) to chemotherapy. lf VTE is diagnosed or predicted in pat1ents treated by carbon-ion at early phase, severe VTE will be prevented by administration of anticoagulants. The pulpose of this study is to evaluate risk Risk of venous thromboembolism with Carbon-ion radiotherapy in cancer patients., 平成23年度HIMAC共同利用研究成果発表会},
 title = {重粒子線治療のおける血栓症寒栓症に関する研究},
 year = {2012}
}